BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33539225)

  • 1. KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy.
    Kyriazis ID; Hoffman M; Gaignebet L; Lucchese AM; Markopoulou E; Palioura D; Wang C; Bannister TD; Christofidou-Solomidou M; Oka SI; Sadoshima J; Koch WJ; Goldberg IJ; Yang VW; Bialkowska AB; Kararigas G; Drosatos K
    Circ Res; 2021 Feb; 128(3):335-357. PubMed ID: 33539225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kir6.1 improves cardiac dysfunction in diabetic cardiomyopathy via the AKT-FoxO1 signalling pathway.
    Wang J; Bai J; Duan P; Wang H; Li Y; Zhu Q
    J Cell Mol Med; 2021 Apr; 25(8):3935-3949. PubMed ID: 33547878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyocyte Krüppel-Like Factor 5 Promotes De Novo Ceramide Biosynthesis and Contributes to Eccentric Remodeling in Ischemic Cardiomyopathy.
    Hoffman M; Palioura D; Kyriazis ID; Cimini M; Badolia R; Rajan S; Gao E; Nikolaidis N; Schulze PC; Goldberg IJ; Kishore R; Yang VW; Bannister TD; Bialkowska AB; Selzman CH; Drakos SG; Drosatos K
    Circulation; 2021 Mar; 143(11):1139-1156. PubMed ID: 33430631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes.
    Yan D; Cai Y; Luo J; Liu J; Li X; Ying F; Xie X; Xu A; Ma X; Xia Z
    J Cell Mol Med; 2020 Jul; 24(14):7850-7861. PubMed ID: 32450616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Myocyte KLF5 Regulates Ppara Expression and Cardiac Function.
    Drosatos K; Pollak NM; Pol CJ; Ntziachristos P; Willecke F; Valenti MC; Trent CM; Hu Y; Guo S; Aifantis I; Goldberg IJ
    Circ Res; 2016 Jan; 118(2):241-53. PubMed ID: 26574507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin IV attenuates diabetic cardiomyopathy
    Zhang M; Sui W; Xing Y; Cheng J; Cheng C; Xue F; Zhang J; Wang X; Zhang C; Hao P; Zhang Y
    Theranostics; 2021; 11(18):8624-8639. PubMed ID: 34522203
    [No Abstract]   [Full Text] [Related]  

  • 7. Weighted Gene Co-Expression Network Analysis Identifies ANGPTL4 as a Key Regulator in Diabetic Cardiomyopathy
    Dai L; Xie Y; Zhang W; Zhong X; Wang M; Jiang H; He Z; Liu X; Zeng H; Wang H
    Front Endocrinol (Lausanne); 2021; 12():705154. PubMed ID: 34616362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous hydrogen sulfide attenuates the development of diabetic cardiomyopathy via the FoxO1 pathway.
    Ye P; Gu Y; Zhu YR; Chao YL; Kong XQ; Luo J; Ren XM; Zuo GF; Zhang DM; Chen SL
    J Cell Physiol; 2018 Dec; 233(12):9786-9798. PubMed ID: 30078216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α.
    Liu F; Song R; Feng Y; Guo J; Chen Y; Zhang Y; Chen T; Wang Y; Huang Y; Li CY; Cao C; Zhang Y; Hu X; Xiao RP
    Circulation; 2015 Mar; 131(9):795-804. PubMed ID: 25637627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Foxo1 by insulin resistance promotes cardiac dysfunction and β-myosin heavy chain gene expression.
    Qi Y; Zhu Q; Zhang K; Thomas C; Wu Y; Kumar R; Baker KM; Xu Z; Chen S; Guo S
    Circ Heart Fail; 2015 Jan; 8(1):198-208. PubMed ID: 25477432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart.
    Xie SY; Liu SQ; Zhang T; Shi WK; Xing Y; Fang WX; Zhang M; Chen MY; Xu SC; Fan MQ; Li LL; Zhang H; Zhao N; Zeng ZX; Chen S; Zeng XF; Deng W; Tang QZ
    Circulation; 2024 Feb; 149(9):684-706. PubMed ID: 37994595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of forkhead box O1 in renal tubular epithelial cells on endotoxin-induced acute kidney injury.
    Zhang M; Dong W; Li Z; Xiao Z; Xie Z; Ye Z; Liu S; Li R; Chen Y; Zhang L; Wang M; Liang H; Baihetiyaer R; Apaer R; Dong Z; Liang X
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F262-F272. PubMed ID: 33356954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid sphingomyelinase promotes diabetic cardiomyopathy via NADPH oxidase 4 mediated apoptosis.
    Liu R; Duan T; Yu L; Tang Y; Liu S; Wang C; Fang WJ
    Cardiovasc Diabetol; 2023 Feb; 22(1):25. PubMed ID: 36732747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycemia-Driven Inhibition of AMP-Activated Protein Kinase α2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes In Vivo.
    Wu S; Lu Q; Ding Y; Wu Y; Qiu Y; Wang P; Mao X; Huang K; Xie Z; Zou MH
    Circulation; 2019 Apr; 139(16):1913-1936. PubMed ID: 30646747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of peroxisome proliferator-activated receptor-alpha alleviates myocardial injury in diabetic cardiomyopathy by downregulating 3-hydroxy-3-methylglutaryl-coenzyme A synthase 2 expression.
    Wang L; Bi X; Han J
    IUBMB Life; 2020 Sep; 72(9):1997-2009. PubMed ID: 32734614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα.
    Yin Z; Zhao Y; He M; Li H; Fan J; Nie X; Yan M; Chen C; Wang DW
    Cardiovasc Diabetol; 2019 Jan; 18(1):7. PubMed ID: 30635067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice.
    Battiprolu PK; Hojayev B; Jiang N; Wang ZV; Luo X; Iglewski M; Shelton JM; Gerard RD; Rothermel BA; Gillette TG; Lavandero S; Hill JA
    J Clin Invest; 2012 Mar; 122(3):1109-18. PubMed ID: 22326951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of FOXO-1 to cardiac pathology in diabetes mellitus and diabetes-related metabolic abnormalities.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Int J Cardiol; 2017 Oct; 245():236-244. PubMed ID: 28781146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
    Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPARα pathway.
    Wu L; Wang K; Wang W; Wen Z; Wang P; Liu L; Wang DW
    Aging Cell; 2018 Aug; 17(4):e12763. PubMed ID: 29659121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.